GB224 10mg
Sponsors
Genor Biopharma Co., Ltd.
Conditions
Rheumatoid Arthritis
Phase 1
Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects
NCT04178070
Start: 2017-11-06End: 2021-04-30Target: 58Updated: 2019-11-27
A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients
NCT04179513
Start: 2019-08-15End: 2021-04-30Target: 24Updated: 2019-11-27